Kaplan–Meier survival analysis revealed that ccRCC patients with high-CYP1B1-expression have poorer overall survival than ccRCC patients with low-CYP1B1-expression (Figure S7C). Here, CYP1B1 is linked to nonpapillary renal cell carcinoma.